OA01.05 Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer- Nadim Study-SLCG

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.236